- $880.81m
- $853.44m
- $82.03m
Paysign surges to near 7-yr high after results, outlook
Paysign Inc reports results for the quarter ended June 30 - Earnings Summary
Paysign Q2 revenue beats estimates; outlook raised amid pharma program expansion
Brief: Paysign Q2 Revenue USD 28.3 Million Vs. IBES Estimate USD 26.3 Million
Paysign Inc expected to post earnings of 6 cents a share - Earnings Preview
Paysign beats Q1 revenue estimates on patient affordability programs
Brief: Paysign Q1 EPS USD 0.09
Paysign Q4 revenue beats estimates on strength in pharma program
Brief: Paysign Q4 EPS USD 0.02
Brief: Paysign Announces 2025 Performance Analysis Of Patient Affordability Solutions
Paysign beats Q3 revenue estimates
Brief: Paysign Q3 EPS USD 0.04
Paysign Inc reports results for the quarter ended June 30 - Earnings Summary
Paysign Q2 revenue up 33%, beats analyst estimates
Paysign Inc expected to post earnings of 4 cents a share - Earnings Preview
Paysign Inc expected to post earnings of 2 cents a share - Earnings Preview
Paysign Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Paysign, Inc. Announces Acquisition of Gamma Innovation’s Assets, Appoints Michael Ngo as Chief Innovation Officer
Paysign Inc expected to post earnings of 2 cents a share - Earnings Preview